Nubain and Post procedural complication - a phase IV clinical study of FDA data

Summary:

Post procedural complication is reported as a side effect among people who take Nubain (nalbuphine hydrochloride), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Solu-Medrol, and have Foetal exposure during pregnancy.

The phase IV clinical study analyzes which people have Post procedural complication when taking Nubain. It is created by eHealthMe based on reports of 1,718 people who have side effects when taking Nubain from the FDA, and is updated regularly.

What is Nubain?

Nubain has active ingredients of nalbuphine hydrochloride. It is often used in pain. eHealthMe is studying from 1,749 Nubain users. Check the latest studies of Nubain.

What is Post procedural complication?

Post procedural complication is found to be associated with 1,088 drugs and 1,362 conditions by eHealthMe. Check the latest studies of Post procedural complication.

On Jul, 09, 2026

1,718 people reported to have side effects when taking Nubain.
Among them, 14 people (0.81%) have Post procedural complication.

Could Nubain cause Post procedural complication?

Among these 14 people:

How long have people been on Nubain when they have Post procedural complication? *

What is the gender of people who have Post procedural complication when taking Nubain? *

female: 64.29 %
male: 35.71 %

What is the age of people who have Post procedural complication when taking Nubain? *

What are other drugs people take besides Nubain? *

What are other side effects people have besides Post procedural complication? *

Arterial Thrombosis Limb (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system-limb): 4 people, 28.57%
Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough): 4 people, 28.57%
Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 28.57%
Colitis Ischaemic (due to infection of intestine impaired blood supply to colon): 4 people, 28.57%
Mitral Valve Incompetence (inefficient heart valve): 3 people, 21.43%
Large Intestine Perforation (hole in large intestine): 3 people, 21.43%
Phlebothrombosis (thrombosis of a vein without prior inflammation of the vein): 3 people, 21.43%
Premature Baby: 3 people, 21.43%
Bradycardia Neonatal (sinus rhythm with a heart rate below the normal limit in newborn): 3 people, 21.43%
Arteritis (inflammation of the walls of arteries): 3 people, 21.43%

What are the existing conditions these people have? *

Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 3 people, 21.43%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 7.14%
Stress And Anxiety: 1 person, 7.14%
Renal Colic (renal pain): 1 person, 7.14%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 7.14%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Nubain and have Post procedural complication?

- Check whether Post procedural complication is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nubain:

Nubain (1,749 reports)

Browse all side effects of Nubain:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Post procedural complication:

Post procedural complication (1,088 drugs)

Browse all the conditions that are associated with Post procedural complication:

Post procedural complication (1,362 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nalbuphine hydrochloride (the active ingredients of Nubain) and Nubain (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.